LC
LCDX.US Caliber Imaging & Diagnostics Inc
- Market cap
- USD 5.10K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2014.
Is LCDX.US undervalued?
Graham numberThe Graham number of Caliber Imaging & Diagnostics Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Caliber Imaging & Diagnostics Inc fundamental analysis
No fundamental analysis for Caliber Imaging & Diagnostics Inc yet.
Caliber Imaging & Diagnostics Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Caliber Imaging & Diagnostics Inc
Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers Vi…
Full company profileCaliber Imaging & Diagnostics Inc financial statements
2014 annualized: Fiscal year 2014 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2014, the balance sheet is the latest quarter. Figures change when the annual report is published.
Caliber Imaging & Diagnostics Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 2.30M | 2.63M | 3.58M | 2.43M | 3.34M | 3.43M |
| Gross Profit | 1.24M | 1.48M | 1.69M | 32.9K | 654K | 569K |
| Operating Income | -3.54M | -3.56M | -6.57M | -8.35M | -4.85M | -6.34M |
| EBITDA | -3.48M | -3.74M | -6.47M | -9.43M | -4.68M | -6.35M |
| Net Income | -4.05M | -4.30M | -9.05M | -9.82M | -5.48M | -7.29M |
| EPS | -1.87 | -1.99 | -4.18 | -1.23 | -0.65 | -0.87 |
| Balance Sheet | ||||||
| Total Assets | 640K | 2.02M | 6.29M | 2.59M | 2.41M | 2.21M |
| Total Liabilities | 9.77M | 10.4M | 6.96M | 10.3M | 14.9M | 16.4M |
| Shareholders' Equity | -9.14M | -8.42M | -665K | -7.71M | -12.5M | -14.2M |
| Cash & Short-term Investments | 29.3K | 839K | 4.90M | 926K | 787K | 230K |
| Total Debt | 4.20M | 6.24M | 3.68M | 7.08M | 11.8M | 5.12M |
| Cash Flow | ||||||
| Operating Cash Flow | -1.44M | -4.01M | -4.50M | -7.70M | -4.84M | -1.94M |
| Capital Expenditure | 15.5K | 15.4K | 124K | 79.5K | 27.7K | 687K |
| Free Cash Flow | -1.46M | -4.03M | -4.50M | -7.78M | -4.86M | -2.63M |
| Ratios | ||||||
| ROA | -633.5% | -213.4% | -143.9% | -379.1% | -227.6% | -329.6% |
| Net Profit Margin | -176.0% | -163.8% | -253.1% | -403.4% | -164.0% | -212.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Caliber Imaging & Diagnostics Inc dividends
Caliber Imaging & Diagnostics Inc has not paid dividends in the last 5 fiscal years.
Who owns Caliber Imaging & Diagnostics Inc
- Insiders 0.00%
- Institutions 0.15%
- Public & others 99.85%
- Shares outstanding 8.51M
Caliber Imaging & Diagnostics Inc company profile
- Company name
- Caliber Imaging & Diagnostics Inc
- Ticker
- LCDX.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 28
- Fiscal year end
- December
- Address
- 100 Burtt Road, Andover, MA, United States, 01810
- Phone
- 585-239-9800
- Website
- caliberid.com
About Caliber Imaging & Diagnostics Inc
Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. Caliber Imaging & Diagnostics, Inc. was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. The company was founded in 1991 and is headquartered in Andover, Massachusetts.
Caliber Imaging & Diagnostics Inc management
3- Mr. William J. SheaExecutive Chairman · born 1948
- Mr. L. Michael HoneCEO & Director · born 1950
- Mr. William J. FoxCTO & VP of Technology Operations · born 1966